Epichaperome inhibition targets TP53-mutant AML and AML stem/progenitor cells.
Carter BZ, Mak PY, Muftuoglu M, Tao W, Ke B, Pei J, Bedoy AD, Ostermann LB, Nishida Y, Isgandarova S, Sobieski M, Nguyen N, Powell RT, Martinez-Moczygemba M, Stephan C, Basyal M, Pemmaraju N, Boettcher S, Ebert BL, Shpall EJ, Wallner B, Morgan RA, Karras GI, Moll UM, Andreeff M.
Carter BZ, et al. Among authors: pei j.
Blood. 2023 Sep 21;142(12):1056-1070. doi: 10.1182/blood.2022019047.
Blood. 2023.
PMID: 37339579
Free PMC article.